2019 Predictions for Late Phase Clinical Trials: Prediction #4

By Michael F. Murphy, M.D., Ph.D., Chief Medical and Scientific Officer at Worldwide Clinical Trials,

 

The need for highly adaptive and innovative information technology permits data acquisition in diverse settings and can capture data from every physician/patient interaction occurring in the context of late phase clinical trials. Our latest blog explores this topic in detail.

Doctor talking to elderly patient

Prediction #4: Back To The Future: Physician/Patient Transactions As An Opportunity For Research

Highly adaptive and innovative information technology permits data acquisition in diverse settings and can capture data from every physician/patient interaction occurring in the context of clinical care.

Additionally, highly innovative trial design methodology permits each of these transactions to be recast as single-case experimental designs. These approaches to clinical research enjoy considerable pedigree within medicine and have often occurred when physicians treat individual patients and formulate hypotheses, which are then confirmed formally by more traditional group techniques. Additionally, because the exchange of information is bidirectional (physician to patient as well as patient to physician), there is the potential to introduce “adaptive” trial methods in which information is accrued collectively and used to modify the behavior of physicians and patients. Sponsors, CROs, and payers create a “back-to-the-future” motif by emphasizing the centrality of individual physician/patient relationships, which historically have been a dynamic interaction that has facilitated the emergence of innovative therapy.

Ready to take the next step in your late phase clinical trial? Contact us!

See what an award-winning CRO can do for you.